CHANGES IN ENDOGENOUS CIRCULATING ANGIOTENSIN AND BRADYKININ AFTER INHIBITION OF CONVERTING ENZYME (KININASE II)

Abstract
Captopril (SQ 14225), a new orally acting angiotensin‐converting enzyme (kininase II) inhibitor, was administered by gavage to normal Sprague‐Dawley rats in doses of 1 mg/kg, 3 mg/kg, and 30 mg/kg. D...